参考文献/References:
[1] Lontchi-Yimagou E,Sobngwi E,Matsha TE,et al.Diabetes mellitus and inflammation[J].Curr Diab Rep,2013,13 (3):435-444.
[2] Chen C,Zhang Y,Huang C.Berberine inhibits PTP1B activity and mimics insulin action[J].Biochem Biophys Res Commun,2010,397 (3):543-547.
[3] Yang J,Yin J,Gao H,et al.Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients[J].Evid Based Complement Alternat Med,2012,2012:363845.
[4] 范梅琳,刘云峰,章毅,等.二甲双胍对脂多糖诱导的THP-1细胞相关炎症因子及凋亡的影响[J].中华内分泌代谢杂志,2013,29(9):801-803.
[5] Sell H,Habich C,Eckel J.Adaptive immunity in obesity and insulin resistance [J].Nat Rev Endocrinol,2012,8:709-716.
[6] Kanter JE,Bornfeldt KE. Inflammation and diabetes-accelerated atherosclerosis:myeloid cell mediators[J].Trends Endocrinol Metab,2013,24(3):137-144.
[7] Luotola K, Pietil?覿 A,Zeller T,et al.Associations between inter-leukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes[J].Intern Med,2011,269(3): 322-332.
[8] Vozarova B,Weyer C,Hanson K,et al.Circulating interleukin-6 in relation to adiposity,insulin action,and insulin secretion[J].Obes Res,2001,9(7):414-417.
[9] Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,inter-leukin-6,and risk of developing type 2 diabetes mellitus [J].JAMA,2001,286(3):327-334.
[10] Ye J,McGuinness OP.Inflammation during obesity is not all bad:Evidence from animal and human studies[J].Physiol Endocrinol Metab,2013,304(5):E466-E477.
[11] Van Sickle BJ,Simmons J,Hall R,et al.Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.[J].Cytokine,2009,48(3):290-294.
[12] Koskela UE,Kuusisto SM,Nissinen AE,et al High vitreous concentration of IL-6 and IL-8,but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy [J].Ophthalmic Res,2013,49 (2):108-114.
[13] Fasshauer M,Paschke R.Regulation of adipocytokines and insulinresistance[J].Diabetologia,2003,46(12):1594-1603.
[14] Ruan H,Miles PD,Ladd CM,et al.Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha:implications for insulin resistance[J].Diabetes,2002,51(11):3176-3188.
[15] Meng S,Wang LS,Huang ZQ,et al.Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention[J].Clin Exp Pharmacol Physiol,2012,39(5):406-411.
相似文献/References:
[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]